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The type III secretion apparatus (T3SA) is a central virulence factor of many Gram-negative
bacteria. Its overall morphology consists of a cytoplasmic region, inner- and outer-membrane
sections and an extracellular needle. In Shigella, the length of the needle is regulated by Spa32.
To understand better the role of Spa32 we searched for its interacting partners using a two-hybrid
screen in yeast. We found that Spa32 interacts with the 33 C-terminal residues (CC*) of Spa40,
a member of the conserved FlhB/YscU family. Using a GST pull-down assay we confirmed this
interaction and identified additional interactions between Spa40 and the type III secretion
components Spa33, Spa47, MxiK, MxiN and MxiA. Inactivation of spa40 abolished protein
secretion and led to needleless structures. Genetic and functional analyses were used to
investigate the roles of residues L310 and V320, located within the CC* domain of Spa40, in the
assembly of the T3SA. Spa40 cleavage, at the conserved NPTH motif, is required for assembly of
the T3SA and for its interaction with Spa32, Spa33 and Spa47. In contrast, unprocessed forms of
Spa40 interacted only with MxiA, MxiK and MxiN. Our data suggest that the conformation of the
cytoplasmic domain of Spa40 defines the multi-step assembly process of the T3SA.
INTRODUCTION
Shigella flexneri, the causative agent of bacillary dysentery
in humans, is able to enter and to disseminate in epithelial
cells by using a specialized Mxi-Spa type III secretion
apparatus (T3SA) (Parsot, 2009). The T3SA is widespread
among Gram-negative bacteria that are pathogenic for
animals and plants or are symbionts (Viprey et al., 1998;
Dale et al., 2001, 2002) and is devoted to the injection of
virulence effectors into target cells. The T3SA is composed
of a cytoplasmic region called ‘the bulb’, a basal body
consisting of a pair of rings that span the inner and outer
membranes, and an extracellular needle protruding outside
the bacterium. This apparatus is evolutionarily and
structurally related to the export machinery of flagellar
systems (Macnab, 1999; Blocker et al., 2001). Nine T3SA
constituents are related to components of the basal bodies
of bacterial flagella (Allaoui et al., 1994; Aizawa, 2001;
Blocker et al., 2003; Macnab, 2004), including the inner-
membrane proteins MxiA (FlhA), Spa9 (FliP), Spa24
(FliR), Spa29 (FliQ) and Spa40 (FlhB), and the cytoplasmic
proteins Spa47 (FliI), MxiN (FliH) and Spa33 (FliN) (Kane
et al., 2002; Allaoui et al., 1992b, 1993b, 1995; Penno et al.,
2006; Jouihri et al., 2003; Andrews & Maurelli, 1992;
Sasakawa et al., 1993; Schuch & Maurelli, 2001; Morita-
Ishihara et al., 2005). Additionally, two cytoplasmic
proteins, Spa13 and MxiK, which have no obvious
counterpart in the flagellar system, are also implicated in
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the assembly of the type III secretion system (T3SS)
(Jouihri et al., 2003; Penno et al., 2006).
Among the battery of T3SA substrates, three classes can be
defined based on their order of transit through the T3SA:
first, the needle subunits of the T3SA, MxiH and MxiI;
then the translocators IpaB, IpaC and IpaD; and finally
effectors such as IpgB1, IpgB2, IpgD and IpaA. The first
switch in secretion from needle subunits to translocators is
regulated by the Spa32 protein. Indeed, mutations in spa32
(Magdalena et al., 2002; Botteaux et al., 2008), as well as in
invJ from Salmonella (SP-1) (Kubori et al., 2000) and yscP
from Yersinia (Journet et al., 2003), lead to abnormally
long needles, suggesting that the system is locked in the
export of needle subunits. Likewise, Salmonella mutants
deficient in fliK, the spa32 counterpart in the flagellar
system, make polyhooks and no filament. Interestingly,
extragenic suppressive mutations that restore filament
assembly on polyhook structures (polyhook-filament
phenotype) have been mapped in flhB, a gene encoding a
major component of the export apparatus (Kutsukake et al.,
1994; Williams et al., 1996; Fraser et al., 2003). FlhB exists
in two processed and unprocessed forms (Minamino &
Macnab, 2000). There is a highly sensitive cleavage site
between amino acids Asn269 and Pro270 in the cytoplasmic
domain of FlhB which is cleaved via an autocatalytic
process involving its own tertiary structure (Ferris et al.,
2005). These residues lie on a conserved amino acid
sequence NPTH in YscU of Yersinia and in Spa40 of
Shigella. The uncleaved form of FlhB permits hook
assembly but not flagellin secretion (Fraser et al., 2003).
The deletion of the entire NPTH motif of YscU leads to an
uncleaved form of the protein and abolishes secretion of
the needle subunit (YscF) (Bjo¨rnfot et al., 2009).
As for YscU and FlhB, Spa40 is also predicted to contain
four transmembrane domains followed by a large cyto-
plasmic one (Allaoui et al., 1994). Deane et al. (2008)
reported that the C-terminal domain of Spa40 (Spa40CT) is
also cleaved within NPTH into two subdomains, Spa40CN
and Spa40CC, which remain tightly associated after
cleavage. The crystal structures of the cytoplasmic domains
of Spa40 (Deane et al., 2008), EcsU from enteropathogenic
Escherichia coli (EPEC), SpaS from Salmonella (Zarivach
et al., 2008) and YscU from Yersinia (Wiesand et al., 2009)
reveal a tight association of the cleaved fragments and show
that the NPTH sequence lies on a loop which, when
cleaved, swings away from the catalytic N257 residue,
resulting in different surface features in this region. This
structural rearrangement suggests a mechanism by which
non-cleaved forms of these proteins interfere with the
substrate specificity switching of the apparatus (Deane
et al., 2008).
While the role of Spa40 in Ipa protein secretion has been
genetically proven (Sasakawa et al., 1993), its involvement
in the secretion process remains poorly understood. In this
study we investigated the molecular role of Spa40 in the
assembly/function of the T3SA. What has emerged is a
picture of Spa40 as a central element of the export
machinery with a critical role in T3SA assembly prior to
the specificity switch.
METHODS
Media and growth conditions. S. flexneri strains were derivatives of
the wild-type strain M90T (serotype 5) (Sansonetti et al., 1982;
Allaoui et al., 1992a). E. coli Top10 strains were transformed with
pSU18, pQE30 or pGEX4T1 derivatives; strain DH5a (lpir) was
transformed with derivatives of the suicide vector pGP704, and
SM10-lpir was used to transfer derivatives of pGP704 to S. flexneri.
Bacteria were grown in tryptic casein soy broth at 37 uC. Antibiotics
were used at the following concentrations: ampicillin, 100 mg ml21;
kanamycin, 50 mg ml21; streptomycin, 100 mg ml21; and chlor-
amphenicol, 25 mg ml21.
Construction of the spa40 null strain For the construction of a
non-polar mutant of spa40, the aphA-3 cassette specifically designed
for the purpose was used (Menard et al., 1993). A non-polar mutant
of spa40 was constructed by replacing the 706 bp SfuI–AccI fragment
internal to spa40 with the SmaI-digested aphA-3 cassette that confers
resistance to kanamycin. In pNJ67, the suicide mutator vector, the
spa40 gene was interrupted between codons 62 and 298. The structure
of pWR100 derivatives carrying the spa40 mutation was confirmed by
PCR using primers Spa40-1 and Spa40-2, and the resulting strains
were designated SM144 or spa40.
Construction of targeted mutations in the cytoplasmic domain
of Spa40. Plasmid pNL3 was constructed by inserting the 1050 bp
EcoRI/HindIII-digested DNA fragment carrying the spa40 gene into
the corresponding sites of the low-expression vector pSU18
(Invitrogen). Substitutions of Spa40 residues at positions G224,
A286, L310 and V320 were made on plasmid pNL3 (Spa40) or pAB51
(GST-Spa40CT) (Botteaux et al., 2009), according to the procedure of
the QuickChange Mutagenesis kit (Stratagene). Each primer used
created a restriction site to easily confirm the introduced mutation
(see Supplementary Table S1). Deletion of Spa40 residues NPTH at
positions 258–261 was done by amplifying the first 771 bp of the
spa40 gene using primers Spa40-3 and Spa40-13, and the last 243 bp
of the spa40 gene with primers Spa40-14 and Spa40-4. Then, the two
PCR fragments were assembled by PCR using primers Spa40-3 and
Spa40-4 and cloned into EcoRI/HindIII-digested pSU18. The resulting
plasmid encoding Spa40DNPTH was named pAB94. The same deletion
was made on pGEX-Spa40CT, and the resulting plasmid encoding
GST-Spa40CT
DNPTH was named pAB98.
Construction of plasmids. Plasmid pAB63, expressing GST-
Spa40CN (residues 205–258), was constructed by inserting a 159 bp
BamHI–EcoRI fragment obtained by PCR using primers Spa40-15/
Spa40-17 into the corresponding sites of pGEX4T1. Plasmid pAB70,
expressing GST-Spa40CC (residues 259–342), was obtained by
inserting a 416 bp BamHI–SmaI PCR DNA fragment obtained using
Spa40-18/Spa40-19 primers into the corresponding sites of
pGEX4T1. Plasmid pAB71, expressing GST-Spa40CC* [glutathione
S-transferase (GST) fused in-frame to residues 309–342 of Spa40]
was constructed by inserting a 266 bp BamHI–SmaI PCR DNA
fragment amplified using primers Spa40-20/Spa40-19 into the
corresponding sites of pGEX4T1. Plasmid pBAL27 was constructed
by inserting a 480 bp PstI–KpnI PCR fragment of the mxiA gene
(using primers MxiA2/MxiA6), encoding the last 160 residues of
MxiA, into the corresponding sites of pBADHisA. Plasmid pBAL26
was constructed by inserting a BamHI–XhoI PCR fragment of the
spa33 gene (using primers Spa33.1/Spa33As) into the corresponding
sites of pBADHisA.
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Production of recombinant proteins and GST pull-down assay.
E. coli strain BL21, harbouring pGEX4T1 or its derivatives (see Table
1) and expressing GST-Spa40CT or its derivatives, was cultured in L-
broth with 100 mg ampicillin ml21 for 2 h at 37 uC, then IPTG was
added to a final concentration of 0.1 mM. After incubation for 3 h at
30 uC, bacteria were harvested and GST fusion proteins were purified
as described by the manufacturer of Gluthathione Sepharose 4B
(Amersham Pharmacia Biotech). Briefly, GST-recombinant proteins
bound to Gluthathione Sepharose 4B (50 ml) were mixed with cleared
extract of E. coli strains expressing His-tagged Spa or Mxi proteins
and incubated overnight at 4 uC. Supernatants were removed by
centrifugation and beads were washed four times with bead-binding
buffer (1 % Triton X-100 in Tris-buffered saline, pH 7.4). After the
final wash, elution was performed with 40 ml glutathione, and 10 ml
SDS-PAGE sample buffer was added to each sample. Bound proteins
were analysed by immunoblotting using anti-His (Sigma) or anti-
GST antibodies (GE Healthcare).
Protein analysis. Crude extracts and culture supernatants of S.
flexneri strains were prepared as described by Allaoui et al. (1993a) and
Botteaux et al. (2009), and analysed by SDS-PAGE and Western
blotting using anti-IpaB (Barzu et al., 1993) and anti-IpaC monoclonal
antibodies (Phalipon et al., 1992) and anti-IpaD (Menard et al., 1993),
anti-MxiI and anti-Spa32 (Magdalena et al., 2002), and anti-IpaA
polyclonal antibodies (Tran Van Nhieu et al., 1997).
Purification of needle complex (NC), electron microscopy and
image analysis. NCs were purified as described by Sani et al. (2007)
and were negatively stained with 2 % uranyl acetate on glow-
discharged carbon-coated copper grids. Electron microscopy was
performed with a Philips CM120FEG electron microscope equipped
with a field emission gun operated at 120 kV. Images were recorded
with a Gatan 4000 SP 4K slow-scan charge-coupled device (CCD)
camera at 680 000 magnification at a pixel size (after binning the
images) of 3.75 A˚ at the specimen level, with GRACE software for
semi-automated specimen selection and data acquisition (Pilgram
et al., 1998). Single-particle analysis, including multi-reference and
non-reference procedures, multivariate statistical analysis and clas-
sification, was performed as described by Sani et al. (2007).
RESULTS
Spa32 interacts with a domain that encompasses
residues 309–342 of Spa40
To identify interaction partners of Spa32, we used the two-
hybrid technique in yeast to screen libraries of prey plasmids
containing DNA fragments from a 65 kb region of the
virulence plasmid encompassing the mxi and spa genes
(Page et al., 2001). The bait plasmid was constructed by
fusing the spa32 gene in-frame with the coding sequence of
the Gal4 DNA-binding domain. For each screen, approxi-
mately 106 diploids carrying the his3 gene under the control
of a Gal4-regulated promoter were spread on plates lacking
His, and the insert carried by the prey plasmid present in
each of the 19 clones that were selected as His+ was
sequenced. Three Spa40 proteins encoded by prey plasmids
Table 1. Strains and plasmids used in this study
Strain or plasmid Relevant features and/or method of construction Source or reference
Strains
M90T-Sm S. flexneri wild-type parental strain (M90T) Allaoui et al. (1992b)
SM144 spa40 mutant This study
Plasmids
pSU18 Expression vector Martinez et al. (1988)
pUC18K pUC derivative carrying the aphA-3 cassette Menard et al. (1993)
pJN67 pGP704 suicide vector carrying the inactivated spa40 gene This study
pNL3 pSU18 expressing Spa40 This study
pAB95 pNL3-Spa40G224F This study
pAB89 pNL3-Spa40A286V This study
pAB87 pNL3-Spa40L310A This study
pAB88 pNL3-Spa40V320K This study
pAB94 pNL3-Spa40DNPTH This study
pAB51 pGEX4T1 expressing GST fused to residues 205–342 of Spa40: GST-Spa40CT Botteaux et al. (2008)
pAB63 pGEX4T1 expressing GST fused to residues 205–258 of Spa40: GST-Spa40CN This study
pAB70 pGEX4T1 expressing GST fused to residues 259–342 of Spa40: GST-Spa40CC This study
pAB71 pGEX4T1 expressing GST fused to residues 309–342 of Spa40: GST-Spa40CC* This study
pAB59 pGEX4T1 expressing GST-Spa40CT
V320K This study
pAB98 pGEX4T1 expressing GST-Spa40CT
DNPTH This study
pAB74 pGEX4T1 expressing GST-Spa40CT
L310A This study
pBAL27 pBADHisA expressing His-MxiAC* (MxiA residues 506–666 fused to 6His) This study
pMS019 pBADHisB expressing His-Spa47 Botteaux et al. (2009)
pJN51 pQE30 expressing His-MxiN Jouihri et al. (2003)
pMJ8 pQE30 expressing His-Spa32 Magdalena et al. (2002)
pJN79 pQE30 expressing His-MxiK Jouihri et al. (2003)
pBAL26 pBADHisA expressing His-Spa33 This study
Role of Spa40 in assembly of Shigella T3SS
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started at residue L279, two at residue E281, one at residue
N283, four at residue R290, two at residue E295, one at
residue V304 and six at residue K309. The region common
to all preys corresponded to residues 309–342 (LYKTHTKY-
SFVDFEHLDEVLRLIVWLEQVENTH) of Spa40.
In a previous work, we demonstrated that residues 206–246
of Spa32 interact with GST-Spa40CT (GST fused to the C-
terminal 137 residues of Spa40), corresponding to the
whole predicted cytoplasmic domain (Fig. 1a; Botteaux
et al., 2008). To test whether residues 309–342 of Spa40 are
sufficient for Spa32 binding we constructed plasmids
pAB70 (encoding GST-Spa40CC, i.e. GST fused to Spa40
residues 259–342), pAB71 (encoding GST-Spa40CC*, i.e.
GST fused to Spa40 residues 309–342) and pAB63 (ending
GST-Spa40CN, i.e. GST fused to Spa40 residues 205–258)
and performed a GST pull-down assay. A soluble extract of
an E. coli strain producing His-Spa32 was incubated with
GST-Spa40 derivatives or GST alone, and bound to
Glutathione Sepharose beads, and proteins retained on
the beads were eluted with glutathione. As reported by
Deane et al. (2008), GST-Spa40CT undergoes a cleavage
that results in the appearance of two forms of Spa40 that
are detected in the eluted fractions with anti-GST
antibodies (corresponding to GST-Spa40CT and GST-
Spa40CN) (Fig. 1c). SDS-PAGE analysis of eluted proteins
indicated that His-Spa32 interacts with GST-Spa40CC and
GST-Spa40CC*, but not with GST-Spa40CN or GST (Fig.
1c). These results confirmed that the last 33 residues of
Spa40 are indeed sufficient for Spa32 binding.
Fig. 1. Residues 309–342 of Spa40 are sufficient for Spa32 binding. (a) Schematic topology of the entire Spa40 protein. The
four transmembrane (TM) domains have previously been reported for YscU (Allaoui et al., 1994). Linear presentation of GST–
Spa40 constructs used in the GST pull-down assay. (b) Sequence alignment (using CLUSTAL W) of Spa40CT with YscU of Y.
enterocolitica and FlhB of Bacillus subtilis. Residues in bold type were mutated in this work. The box represents the Spa40
domain identified as interacting with Spa32. (c) Eluted fractions (EF) from GST and GST–Spa40CT variants, after incubation
with the cleared extract of E. coli producing His-Spa32, were analysed by SDS-PAGE and immunoblotting using anti-GST or
anti-His antibodies.
A. Botteaux and others
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The spa40 mutant is defective in secretion and
exhibits a needleless structure
To investigate further the role of Spa40, we inactivated the
spa40 gene in the S. flexneri wild-type strain M90T (see
Methods). To assess the ability of the spa40 mutant to
secrete Ipa proteins, whole-cell extracts and proteins
secreted by the wild-type and spa40 mutant were analysed
by SDS-PAGE and Coomassie blue staining (Fig. 2a) or by
immunoblotting with antibodies against the needle com-
ponent MxiI or Spa32, translocators (IpaB, IpaC and IpaD)
and an effector (IpaA) (Fig. 2b). Similar amounts of these
proteins were present in whole-cell extracts of the two
strains (Fig. 2b), and they were all secreted by the wild-type
strain but not by the spa40 mutant. Secretion was restored
upon complementation of the spa40 mutant with pNL3, a
low-copy plasmid expressing native Spa40 (Fig. 2a, b).
To characterize the T3SA structure of the spa40 mutant,
extensively purified NCs were analysed by transmission
electron microscopy (TEM). The spa40 mutant produced
T3SAs lacking the needle portion (Fig. 2c). In parallel, we
also purified NCs and analysed the T3SAs of mxiA and
spa47 mutants that also lack the needle structure (Fig. 2c).
Average analysis of 2D projections of purified basal body
particles revealed that the spa40 mutant exhibited a
structure slightly different from that of the mxiA and
spa47 mutants. Indeed, a dense region observed at the
lower end of the bulge in mxiA and spa47 mutants was
missing from the corresponding structure of the spa40
mutant (Fig. 2c, d), which may reflect the position of Spa40
within the NCs.
Mutational and functional analysis of the
C-terminal domain of Spa40 (Spa40CT)
Sequence alignment of members of the Spa40 family,
including FlhB of Salmonella typhimirium and YscU of
Yersinia enterocolitica, pointed to a number of conserved
residues (Fig. 1b). As some of these residues are known to
be mutagenic suppressors in other systems (Williams et al.,
1996; Edqvist et al., 2003; Kutsukake et al., 1994), we
mutated the corresponding codons on plasmid pNL3 to
construct Spa40 variants G224F in the CN domain and
A286V, L310A and V320K in the CC domain. The last two
residues were chosen for their location within the Spa40-
interacting domain and for their conservation among
Spa40/YscU family proteins (Fig. 1b). Plasmids expressing
Spa40 variants were introduced into the spa40 mutant and
tested for their ability to restore secretion. Mutations
G224F and A286V did not affect Spa40 function, but
mutations V320K and L310A abolished secretion of all
tested T3SA substrates (Fig. 3a). The fact that the needle
component MxiI was not detectable in the supernatant
(Fig. 3a) suggested that the V320K and L310A mutations
Fig. 2. The spa40 mutant is deficient in secretion and exhibits a needleless substructure. Culture supernatant (Sup.) and whole-
cell extracts (WCE) of M90T (wild-type), spa40 and spa40/pNL3 (expressing Spa40) were analysed by SDS-PAGE and
Coomassie blue staining (a) or by immunoblotting with antibodies against MxiI, Spa32, IpaB, IpaC, IpaD or IpaA (b). (c) Electron
microscopy 2D average projections of purified NC particles isolated from spa40, mxiA and spa47 mutants. The arrow points to
the position of a dense region seen in the mxiA and spa47 mutants but missing in the spa40 mutant. (d) Basal view showing the
basal body structure of the spa40 mutant lacking the upper outer rings and the lower supporting dense region.
Role of Spa40 in assembly of Shigella T3SS
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affect the assembly of the T3SA. To test this hypothesis, we
investigated the presence of the needle structure in these
strains by electron microscopy and found that bacteria
expressing the L310A or V320K variant lacked the needle
part (Fig. 3c).
Spa40 interacts via its C-terminal domain with
MxiA, MxiN, MxiK, Spa47 and Spa33
Since the L310A and V320K mutations affected the export
of MxiI, we reasoned that Spa40CT may interact with other
T3SA components. To test this hypothesis, we performed
GST pull-down assays with other Mxi and Spa compo-
nents, including MxiA, MxiN, Spa47, MxiK and Spa33,
whose corresponding mutated strains exhibit a needleless
phenotype (Jouihri et al., 2003; this study; our unpublished
data). MxiK, MxiN, Spa47 and Spa33 are soluble proteins,
while the overall secondary structure of MxiA indicates the
presence of seven hydrophobic domains followed by a large
cytoplasmic C-terminal domain. To test for interactions
between Spa40 and these proteins, we performed a GST
pull-down assay as described above. Analysis of the eluted
fraction with glutathione indicated that Spa40CT interacted
with all tested proteins (Fig. 4), but not with His-
DNMT3a, which encodes a His-DNA-methyltransferase-
3-a used as a control. All interactions were detected in E.
coli, indicating that Spa40 binding to its partners does not
require intermediate T3SA components. To investigate
further the binding domain(s) of Spa40, we performed a
similar GST pull-down assay with GST-Spa40CN, GST-
Spa40CC and GST-Spa40CC*. The CC* domain, which is
sufficient for Spa32 binding, was found to interact with
MxiAC*, MxiN and Spa33. Spa47 bound to the CN
domain, but not to the CC one (Fig. 4). Lastly, MxiK,
the ATPase cofactor, bound weakly to Spa40CN, and not at
all to Spa40CC and Spa40CC*.
Fig. 3. Residues L310 and V320 are required for protein secretion. (a, b) Whole cell extracts (WCE) and proteins of the culture
supernatant (Sup.) of M90T (wild-type; WT), spa40 and spa40 harbouring plasmid pNL3 (expressing Spa40) or its derivatives
encoding Spa40G224, Spa40A286, Spa40L310 or Spa40V320 were analysed by SDS-PAGE and Coomassie blue staining or by
immunoblotting with antibodies directed against MxiI, Spa32, IpaD, IpaC, IpaB or IpaA. (c) Electron micrographs of negatively
stained bacteria: spa40, spa40 complemented with native Spa40, Spa40L310, Spa40V320 or Spa40DNPTH. Visualization by
electron microscopy of NCs associated with bacteria. Arrowheads indicate the positions of needle substructures protruding
from the bacterial surface. Bars, 100 nm.
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Mutation of residues L310A and V320K affects
Spa40 interaction with Spa32, MxiA and MxiN
As the same domain of Spa40 is critical for Spa32, MxiA,
MxiN and Spa33 binding, we constructed two derivatives
of GST-Spa40CT mutated at residues V320 and L310.
Analysis of eluted fractions of GST-Spa40CT
L310A and GST-
Spa40CT
V320K revealed that these two mutations affect the
correct cleavage of Spa40CT (Fig. 5a, b). We next used these
two variants in a GST pull-down assay. GST-Spa40CT
L310A
and GST-Spa40CT
V320K were not able to interact with His-
Spa32. GST-Spa40CT
L310A, the production of which was
remarkably reduced compared with GST-Spa40CT, did not
interact with MxiN or MxiK, while the interaction of GST-
Spa40CT
V320K with MxiAC* was drastically reduced (Fig.
5c). In contrast, GST-Spa40CT
L310A and GST-Spa40CT
V320K,
like native GST-Spa40CT, were still able to interact with
both Spa33 and Spa47 (Fig. 5c). The L310A and V320K
mutations may introduce a misfolding by altering the side
chains of residues that pack in the hydrophobic core of
Spa40. However, as certain interactions are still maintained
with these mutants, misfolding is unlikely to explain the
absence of interaction with some type III secretion (T3S)
components.
Deletion of the NPTH motif abolishes Spa40
processing and affects assembly of the T3SA
To understand better the role of the cleavage per se, we
constructed an in-frame deletion of the region encoding
the NPTH motif on GST-Spa40CT. As expected, the GST-
Spa40CT
DNPTH protein was not cleaved (Fig. 6a). Next, we
tested the effect of this mutation on protein secretion by
complementing the spa40 mutant with pAB94, a plasmid
encoding Spa40DNPTH. The latter did not restore the
secretion defect of the spa40 mutant (Fig. 6b). MxiI, the
minor needle component, accumulated in the lysate of the
spa40/Spa40DNPTH strain compared with the wild-type and
spa40/pNL3 strains (Fig. 6b). TEM analysis confirmed the
absence of the needle assembly in spa40/Spa40DNPTH (Fig.
3c), indicating that Spa40 cleavage is important for NC
assembly.
Spa40DNPTH interacts with MxiA, MxiK and MxiN,
but not with Spa32, Spa33 or Spa47
To test whether the cleavage of Spa40 interferes with its
ability to associate with identified interacting partners, we
performed a GST pull-down assay. GST-Spa40CT
DNPTH was
no longer able to interact with His-Spa32, His-Spa33 or
His-Spa47 (Fig. 6c). In contrast, the unprocessed form was
still able to interact with MxiAC, MxiK and MxiN (Fig. 6c).
The NPTH deletion entirely removes the loop connecting
the central b-strands that form the core of the Spa40 fold,
Fig. 4. Spa40 interacts with several T3SS components. SDS-
PAGE and immunoblotting analysis of eluted fractions (EF) from
GST-Spa40CT, GST-Spa40CN, GST-Spa40CC, GST-Spa40CC*
and GST alone after incubation with cleared extract (CE) of E. coli
strains producing His-MxiAC*, His-MxiN, His-MxiK, His-Spa47 or
His-Spa33. His-DNMT3a, negative control.
Fig. 5. Residues L310 and V320 are required for Spa40 binding
to Spa32, MxiA, MxiN and MxiK. Fractions eluted (EF) upon
purification of GST-Spa40CT, GST-Spa40CT
L310 or GST-
Spa40CT
V320 were analysed by SDS-PAGE and Coomassie blue
staining (a) or immunoblotting with antibodies against GST (b) or
His-tag (c) after incubation of these beads with the cleared extract
(CE) of E. coli producing His-Spa32, His-MxiAC*, His-MxiN, His-
MxiK, His-Spa47 and His-Spa33. His-DNMT3, negative control.
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which could consequently generate a misfolded protein.
However, the inclusion of GST-Spa40CT
DNPTH in our
analysis is supported by the fact that certain interactions
with MxiAC*, MxiK and MxiN are maintained. In
conclusion, Spa40 processing is likely to reflect a
cytoplasmic conformational change that defines its binding
specificity.
DISCUSSION
The assembly of the T3SA needle is a carefully orchestrated
multi-step process that requires the coordination of many
proteins located in the cytosol, in membranes and on the
bacterial cell surface. In the present study, we investigated
the role of Spa40, and report structural and functional
evidence that supports the concept that Spa40 processing
directs selective molecular interactions with several T3SA
components, such as Spa32, Spa33, Spa47, MxiK, MxiN
and MxiA (Table 2). To get insight into Spa32 function in
the switch, we first searched for its interacting partners and
identified a domain encompassing residues 309–342 of
Spa40 that is sufficient for Spa32 binding. The spa40
mutant lacks a dense region at the central base of the NC
basal body, which may reflect the position of Spa40 in this
structure, confirming earlier work that established that
Spa40 is a minor component of the central inner-
membrane export apparatus (Zenk et al., 2007).
To characterize further the role of the C-terminal domain,
we examined the effect of single amino acid residue
mutations within Spa40. Mutations of L310 or V320, both
of which are conserved among Spa40 homologues,
abolished the needle assembly and Spa32 binding. L310 is
part of a conserved consensus sequence LARXLY, located
near a positively charged patch mapped to helix a3, which
lies directly below the NPTH loop region (Deane et al.,
2008). This position suggests that it may play a role in the
recruitment of T3SA components (Deane et al., 2008).
Indeed, we found that Spa40 interacts with Spa33, Spa47,
MxiN, MxiK and MxiAC. These interactions, except those
with Spa47 and MxiK, involve the last 33 residues of Spa40,
suggesting that some competition may occur during the
assembly process. We have previously reported that a
Shigella strain mutated in spa47, mxiN or mxiK does not
assemble the needle substructure because of the instability
of MxiH and MxiI in the bacterial cytoplasm, suggesting
that the preliminary function of the Spa47 ATPase is to
ensure the transit of the needle components. In line with
this hypothesis, the FliH–FliI interaction with FlhBC (Zhu
et al., 2002) facilitates the initial entry of exported
substrates into the gate, with the energy of ATP hydrolysis
Fig. 6. Deletion of the NPTH motif abolishes Spa40 cleavage, assembly of the T3SA and binding to Spa32, Spa33 and Spa47.
(a) Analysis of eluted fractions (EF) of GST-Spa40CT and GST-Spa40CT
DNPTH by SDS-PAGE and Coomassie blue staining. (b)
Proteins present in culture supernatants (Sup.) and whole cell extracts (WCE) of M90T (wild-type; WT), spa40 mutant, spa40/
Spa40 or spa40/Spa40DNPTH were analysed by immunoblotting with antibodies directed against MxiI, Spa32, IpaB, IpaC and
IpaA. (c) SDS-PAGE and immunoblotting analysis of eluted fractions (EF) from beads coated with GST-Spa40CT or GST-
Spa40CT
DNPTH after incubation with the cleared extract of E. coli producing His-Spa32, His-MxiAC*, His-MxiN, His-MxiK, His-
Spa47 or His-Spa33. His-DNMT3a, negative control.
A. Botteaux and others
2814 Microbiology 156
being used to disassemble and release the FliH–FliI
complex from the protein to be exported (Minamino &
Namba, 2008). Recently, the large cytoplasmic domain of
YscU has been defined as necessary for the recruitment of
the YscN ATPase regulatory complex, YscK–YscL–YscQ, in
Yersinia (Riordan & Schneewind, 2008). The interaction
identified here between the Spa40CN domain and Spa47
and MxiK may permit the correct positioning or
movement of the Spa40CC domain and its recruitment of
needle subunits or other components. The L310A mutation
drastically reduced Spa40–MxiN binding, while the V320K
mutation reduced the Spa40–MxiAC* interaction, suggest-
ing that the binding domain of Spa40 is part of the last a-
helix. Based on these results, we propose that the specific
interaction of Spa40 with MxiAC* or MxiN is essential for
the early events of needle assembly.
We investigated the role of Spa40 cleavage per se by
constructing a Spa40 variant lacking the NPTH motif.
Spa40DNPTH was not functional and was no longer able to
interact with Spa32, Spa33 and Spa47, but still bound
MxiA, MxiN and MxiK. The interaction of MxiAC* or
MxiN with Spa40DNPTH was not seen with Spa40L310A and
Spa40V320K variants, which were also uncleaved, suggesting
that residues L310 and V320 are directly part of the binding
site. Therefore, our results strongly suggest that the altered
function of the unprocessed form of Spa40 results from
loss of binding or recognition of other T3SS components.
Studies on EscU and SpaS, the Spa40 counterparts of EPEC
and Salmonella, highlight the importance of the cleavage in
T3S function (Zarivach et al., 2008). Structural and in vivo
analysis of specific mutations within EscU illustrate the
conformational effects of auto-cleavage in modulating the
EscU region involved in interactions with other T3SS
components at the inner membrane (Zarivach et al., 2008).
One intriguing result that we obtained concerns the
intracellular accumulation of the minor needle component
MxiI in strain spa40/Spa40DNPTH. This suggests that Spa40
processing controls MxiI secretion before the assembly of
the NC basal body. In comparison, a recent study has
highlighted the critical role of the inner rod protein YscI,
the Yersinia MxiI counterpart, in the substrate specificity
switch. Indeed, it was reported that the formation of the
inner rod, not the needle, is critical for substrate specificity
switching, and that YscP and YscU exert their effects on
substrate export by controlling YscI secretion (Wood et al.,
2008). Thus, as suggested for PrgJ/YscI (Marlovits et al.,
2004), MxiI may form a rod-like structure inside the base
that is required for needle stability and may function as a
platform for the initiation of needle polymerization
(Marlovits et al., 2006; Wood et al., 2008).
In conclusion, based on our results and on accumulating
data from the literature, we propose a model in which the
cleaved form of Spa40 interacts with MxiK and MxiN,
leading to the recruitment of the ATPase Spa47 at the T3S
basal body structure. In addition, the novel conformation
of Spa40CC, within the MxiK–Spa47–MxiN complex,
exposes certain residues that facilitate its interaction with
Spa33, which is known to interact with the two inner-
membrane T3S components MxiG and MxiJ. This
configuration permits the transit of the needle components
MxiI and MxiH. Later, once the needles reach 50 nm,
Spa32 could compete with MxiN for interaction with the
Spa40CC domain to stop MxiH secretion, leading to the
switch to translocator secretion. Consequently, a confor-
mational change in the ATPase Spa47 would control the
switch in substrate specificity from needle components to
effectors, as has been suggested for the switch from
translocators to later effectors (Botteaux et al., 2009).
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